Ken Griffin Sanara Med Tech Inc. Transaction History
Citadel Advisors LLC
- $618 Billion
- Q3 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sanara Med Tech Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 19,054 shares of SMTI stock, worth $409,661. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19,054
Previous 22,773
16.33%
Holding current value
$409,661
Previous $646,000
8.05%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding SMTI
# of Institutions
55Shares Held
1.13MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY197KShares$4.24 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA182KShares$3.91 Million0.0% of portfolio
-
Stonebridge Wealth Management, LLC Oak Brook, IL135KShares$2.9 Million2.98% of portfolio
-
Geode Capital Management, LLC Boston, MA78.5KShares$1.69 Million0.0% of portfolio
-
Marshall Wace, LLP London, X066.1KShares$1.42 Million0.0% of portfolio
About Sanara MedTech Inc.
- Ticker SMTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 8,303,730
- Market Cap $179M
- Description
- Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and...